Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
•
Primary Care
Is there any reason to stop mesalamine in a patient with UC undergoing breast/regional nodal radiation?
Answer from: Radiation Oncologist at Community Practice
I have run into this situation a few times and have not stopped mesalamine during breast radiation. Have not noticed any issues.
Sign In
or
Register
to read more
11392
Related Questions
How do you assess and counsel women with chronic post-lumpectomy or mastectomy pain?
What is the maximum dose that you would give to residual unresectable gross disease in the axilla in the setting of recurrent breast cancer s/p ALND?
When do you start adjuvant radiation with areas of delayed wound healing after reduction mammoplasty?
Does delay to the time of lumpectomy impact your decision to omit radiation?
Would you consider RNI alone without CW for an isolated nodal recurrence after treatment with mastectomy and SNB for an early-stage breast cancer with no prior RT?
Does micropapillary subtype for a G1-2 DCIS affect your radiation treatment recommendations?
What are your top takeaways in Breast Cancer from ESMO 2025?
Do you offer hypofractionation or RNI for a pT1N0 high-grade primary neuroendocrine carcinoma of the breast?
In what patients is it inappropriate to offer DCISionRT testing?
How do you approach breast hypofractionation RNI with the results of the Skagen Trial 1?